Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Clinical Genetics|February 24, 2026
Exploring the Impact of RNU4-2 Defects on Neurodevelopmental Disorders in a Korean PopulationJuhyeon Hong, Seungbok Lee, Soo Yeon Kim, et al.Cancer Research|March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor ImmunityLinlin Sun, Chia-Wei Li, Ezra M Chung, et al.The Journal of Biological Chemistry|December 19, 2013
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in miceBum Ju Ahn, Hoang Le, Min Wook Shin, et al.The Journal of Biological Chemistry|June 12, 2014
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamicsBum Ju Ahn, Hoang Le, Min Wook Shin, et al.Cancer Cell|November 22, 2016
Deubiquitination and Stabilization of PD-L1 by CSN5Seung-Oe Lim, Chia-Wei Li, Weiya Xia, et al.Journal of Medicinal Chemistry|November 29, 2012
Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesisDong-Jo Chang, Hongchan An, Kyoung-suk Kim, et al.The Journal of Biological Chemistry|March 12, 2022
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancerJong-Ho Cha, Li-Chuan Chan, Ying-Nai Wang, et al.Nature Communications|August 31, 2016
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityChia-Wei Li, Seung-Oe Lim, Weiya Xia, et al.The Journal of Clinical Investigation|July 16, 2019
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasionLi-Chuan Chan, Chia-Wei Li, Weiya Xia, et al.Cancer Research|May 27, 2010
Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferationJi Hae Seo, Jong-Ho Cha, Ji-Hyeon Park, et al.Pageof 9